Stock comparison
Boston Scientific
Stryker
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BSX
Boston Scientific
Market cap
$78.3B
Sector
Healthcare
SYK
Stryker
Market cap
$117.6B
Sector
Healthcare
Overall winner
Stryker SYK
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BSX | SYK | Winner |
|---|---|---|---|
| Warren Buffett | 57C | 57C | Tie |
| Benjamin Graham | 63C | 75B |
Side-by-side metrics
| Metric | BSX | SYK |
|---|---|---|
| Market cap | $78.3B | $117.6B |
| P/E (TTM) | 22.0x | 35.2x |
| EV/EBIT | 22.1x | 26.4x |
| ROIC (TTM) | 9.9% | 9.79% |
| Gross margin | 70.41% | 63.67% |
| Net margin | 17.24% | 13.21% |
| Revenue CAGR 5y | 13.99% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BSX leads on
- EPS CAGR 5y29.71%vs 12.55%+58%
- P/E (TTM)22.0xvs 35.2x+37%
- Debt / Equity0.4xvs 0.6x+33%
- Revenue CAGR 5y13.99%vs 10.07%
More like SYK
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.